BECONASEAQ (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the BECONASE drug offered from GlaxoSmithKline LLC. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
NON-PROPRIETARY NAME: | beclomethasone dipropionate monohydrate |
SUBSTANCE NAME: | BECLOMETHASONE DIPROPIONATE MONOHYDRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
ROUTE: | NASAL |
DOSAGE FORM: | SPRAY, SUSPENSION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1989-10-01 |
END MARKETING DATE: | 0000-00-00 |
BECONASE AQ HUMAN PRESCRIPTION DRUG Details:
Item Description | BECONASE AQ from GlaxoSmithKline LLC |
LABELER NAME: | GlaxoSmithKline LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 42(ug/1) |
START MARKETING DATE: | 1989-10-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0173-0388_17600f11-d034-4c3d-974f-8287b42db37a |
PRODUCT NDC: | 0173-0388 |
APPLICATION NUMBER: | NDA019389 |
Other BECLOMETHASONE DIPROPIONATE MONOHYDRATE Pharmaceutical Manufacturers / Labelers: